Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · IEX Real-Time Price · USD
17.20
-0.65 (-3.64%)
Jun 2, 2023, 11:32 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 |
|---|---|---|
| Selling, General & Admin | 13.55 | 3.56 |
| Research & Development | 55.63 | 38.23 |
| Operating Expenses | 69.18 | 41.79 |
| Operating Income | -69.18 | -41.79 |
| Other Expense / Income | -4.41 | 0.05 |
| Pretax Income | -64.77 | -41.84 |
| Net Income | -64.77 | -41.84 |
| Shares Outstanding (Basic) | 2 | 1 |
| Shares Outstanding (Diluted) | 2 | 1 |
| Shares Change | 126.58% | - |
| EPS (Basic) | -41.59 | -60.87 |
| EPS (Diluted) | -41.59 | -60.87 |
| Free Cash Flow Per Share | -39.50 | -7.24 |
| EBITDA | -64.77 | -41.84 |
| EBIT | -64.77 | -41.84 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).